June Lee

This profile gathers the share dealings of June Lee across 2 companies, led by MyoKardia, Inc. and Eledon Pharmaceuticals, Inc. In total, 35 filings cover trades dated from 30 April 2018 to 10 January 2026.

No open-market purchase appears, only 12 sales worth €1.8M. The rest of the record consists of 4 share grants and 19 option exercises.

The latest filing, published on 16 January 2026, reports an option exercise in Eledon Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.